Advanced Micro Devices on Wednesday introduced its latest processors for AI-powered personal computers and workstations at the Computex trade show in Taiwan. AMD is looking to take PC market share from struggling rival Intel. But AMD stock and Intel stock both fell on Wednesday.
At Computex, AMD announced a strengthened partnership with Taiwan-based PC maker Asus. The computer builder introduced its Asus Expert P Series Copilot+ PCs, a lineup of commercial PCs running AMD Ryzen processors. The top-of-the-line machine uses an AMD Ryzen AI Pro 300 series processor.
AMD says the new computers will bring AI acceleration to the enterprise. They offer more than 50 TOPS (trillions of operations per second) of neural processing unit (NPU) performance for faster and more efficient AI productivity, AMD says. They're also designed to support the next generation of Microsoft Copilot+ artificial intelligence experiences.
AMD also showed off its Radeon RX 9060 XT graphics cards for next-gen gaming. Plus, it touted its latest Ryzen Threadripper processors and Radeon graphics cards for high-end workstations.
On the stock market today, AMD stock climbed as much as 2.3% before reversing. It ended the regular session down 1.3% to 112.06. Meanwhile, Intel stock closed at 20.69, down 2.7% for the day.
In the first quarter, AMD grabbed 24.4% of the market for x86 PC central processing units, up from 20.8% in the year-earlier period, according to Mercury Research. Intel took 75.6% of the CPU market, down from 79.2% in the same quarter last year.
On Monday at Computex, Intel introduced new graphics processing units and AI accelerators for PCs and data centers.
In other news, Reuters reported Tuesday that Intel is exploring the sale of its network and edge businesses as the company looks to divest non-core assets.
In April, Intel announced a deal to sell 51% of its Altera business to private equity giant Silver Lake. Altera makes field-programmable gate array (FPGA) chips.
AMD stock has an IBD Relative Strength Rating of 21 out of 99, according to IBD Stock Checkup. That puts it in the bottom quartile for performance out of all stocks over the past 52 weeks. Meanwhile, Intel stock has an IBD RS Rating of 19.
Follow Patrick Seitz on X, formerly Twitter, at @IBD_PSeitz for more stories on consumer technology, software and semiconductor stocks.
